HIGHLIGHTS
- who: Tumors and collaborators from the Tumour Hospital of Mudanjiang eSciPub LLC, Houston, TX USA have published the research work: *Correspondence to Author: LIU Gang Tumour Hospital of Mudanjiang How to cite this article:, in the Journal: (JOURNAL)
- what: The authors evaluated the effectiveness and safety of Apatinib Mesylate tablet in the treatment of
SUMMARY
Dose Apatinib, 250-500mg, qd; 28 days as a cycle; Object Response Rate (ORR) The proportion of patients whose tumors have shrunk to a certain amount and maintained for a certain period of time, including cases . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.